Petros Pharmaceuticals, Inc. (PTPI)

NASDAQ: PTPI · IEX Real-Time Price · USD

0.713

+0.033 (4.91%)

At close: May 3, 2024, 4:00 PM

0.700

-0.013 (-1.86%)

After-hours: May 3, 2024, 7:56 PM EDT

Petros Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.34	9.43	23.85	17.14	2.15
Cash & Cash Equivalents	13.34	9.43	23.85	17.14	2.15
Cash Growth	41.49%	-60.47%	39.14%	698.75%	-
Receivables	2.23	2.11	2.46	5.15	2.61
Inventory	2.79	1.82	0.52	0.76	2.2
Other Current Assets	2.03	1.32	3.72	2.85	5.13
Total Current Assets	20.39	14.67	30.54	25.91	12.09
Property, Plant & Equipment	0.26	0.4	0.05	0.06	0.07
Goodwill and Intangibles	8.97	12.24	25.29	32.16	38.81
Other Long-Term Assets	4.18	5.11	11.5	11.72	7.4
Total Long-Term Assets	13.41	17.75	36.85	43.95	46.28
Total Assets	33.8	32.42	67.39	69.85	58.37
Accounts Payable	1.71	1.81	4.56	5.61	3.78
Current Debt	1.16	1.09	0	7.18	6.68
Other Current Liabilities	7.9	4.17	26.42	29.11	30.65
Total Current Liabilities	10.77	7.07	30.98	41.89	41.1
Long-Term Debt	6.86	8.39	0	0	7.06
Other Long-Term Liabilities	3.69	0.26	0.87	10.49	2.18
Total Long-Term Liabilities	10.55	8.65	0.87	10.49	9.24
Total Liabilities	21.32	15.72	31.85	52.38	50.35
Total Debt	8.01	9.48	0	7.18	13.74
Debt Growth	-15.45%	-	-	-47.79%	-
Retained Earnings	-98.89	-90.73	-70.69	-61.7	-41.12
Shareholders' Equity	12.07	16.7	35.54	17.47	8.02
Net Cash / Debt	5.32	-0.05	23.85	9.96	-11.6
Net Cash / Debt Growth	-	-	139.32%	-	-
Net Cash Per Share	2.45	-0.02	21.90	18.66	-47.14
Working Capital	9.62	7.6	-0.44	-15.99	-29.02
Book Value Per Share	5.55	8.07	32.64	32.71	32.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).